Yuhan Corp will distribute Canesten·Bepanthen
By Nho, Byung Chul | translator Alice Kang
24.12.30 05:50:15
가나다라
0
Last year's sales of Bepanthen-Canesten, KRW 8.9-3.7 billion...the expanded lineup expected to drive performance
The company had conducted aggressive marketing activities upon acquisition of Vivozon Pharmaceutical’s fatigue recovery drug Lalaola in 2023
Had endeavored to strengthen the performance of newly introduced OTC products through 15,000 pharmacy partners nationwide
Yuhan Corp has been selected as the new distribution partner for Bayer’s Canesten and Bepanthen.
According to industry sources, Bayer Korea recently terminated its 10-year co-promotion agreement with Ildong Pharmaceutical and signed a new distribution agreement with Yuhan Corp.
Under the new agreement, Yuhan Corp will take over the domestic distribution of Bayer's flagship products ▲ Canesten Cream (antifungal), Vaginal Tablets (vaginitis treatment), Powder (infant antifungal), and Bepanthen Ointment (diaper rash treatment).
Based on drug distribution performance, Bepanthen and Canesten recorded sales of KRW 8.9 billion and KRW 3.7 billion, respectively, last yea
Nho, Byung Chul(sasiman@dailypharm.com)
If you want to see the full article, please JOIN US (click)